Skip to main content
. 2015 Feb 16;30(3):200–203. doi: 10.1002/jcla.21836

Table 1.

Personal Characteristics, Activities of Liver Enzymes, Cd4+ Cell Counts, and Activities of Adenosine Deaminases in Healthy Subjects and Infected Patients

Subjects N Gender M/F Age‐Year Mean (Range) AST (U/L) Mean (SD) ALT (U/L) Mean (SD) ALP (U/L) Mean (SD) CD4+ count (Cells/μL) Mean (SD) tADA (U/L) Mean (SD) ADA1 (U/L) Mean (SD) ADA2 (U/L) Mean (SD)
Control 72 71/1 35 (25–60) 27.2 (4.0)a,b,f 38.2 (5.4)a,b,c 85.1 (3.6) 1748.3 (354.3)a,b,c,d 23.4 (11.0)a,b,d,e 6.3 (3.9)a 16.4 (9.7)a,b,d,e
HIV 33 28/5 36 (30–55) 36.0 (2.9)a,c,d 48.1 (3.6)a,d,e,g 86.9 (6.1) 522.8 (275.4)a 51.5 (12.5)a,c,f,g 8.1 (5.3) 43.4 (12.5)a,c,f,g
All coinfections 60 57/3 34 (23–55) 34.1 (9.1)f 43.1 (9.1)g 85.7 (4.3) 445.1 (218.5)b 60.8 (12.2)b,c 8.2 (5.2) 52.7 (12.8)b,c
HIV‐HBV 30 30/0 34 (25–54) 42.5 (4.2)b,c,e 51.3 (3.8)b,d,f 86.7 (9.4) 387.7 (181.5)c 59.7 (12.5)d,f 8.4 (5.4)a 51.4 (13.2)d,f
HIV‐HCV 30 27/3 35 (23–55) 26.4 (4.0)d,e 35.5 (4.7)c,e,f 84.8 (4.0) 517.7 (249.5)d 58.7 (12.7)e,g 7.7 (4.9) 50.9 (15.3)e,g

SD, standard deviation; data represented as Mean (SD).

F, female; M, male; U/L, units per liter of enzyme activity.

In each column, data with similar superscript letters (a–g) represents significant difference (P < 0.05) between groups

and represent significant difference of given coinfected group compared with HIV monoinfected subjects with a P value of P = 0.01 and P = 0.02, respectively.